Oxytocin alleviated colitis and colitis-associated colorectal tumorigenesis by targeting fucosylated MUC2
暂无分享,去创建一个
Lixiang Li | Yanqing Li | Jingxin Li | Dawei Chen | Xia Wang | Xiao-heng Xie | Dong Zhao | Jing Guo | Shi-yu Li | Mengnan Guo | Yao Ning | Jiahui Gao | Xiu-li Zuo
[1] Jianxin Zhao,et al. L-Fucose increases the fucosylation of colorectal cancer cells via promoting the accumulation of serine. , 2023, Food & function.
[2] N. Schultz,et al. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers , 2023, Nature Communications.
[3] Huimin Qi,et al. Hormone supply to the pituitary gland: A comprehensive investigation of female-related tumors (Review) , 2022, International journal of molecular medicine.
[4] C. Dai,et al. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis , 2021, EBioMedicine.
[5] Jennifer J. Kohler,et al. Interleukin-22 regulates B3GNT7 expression to induce fucosylation of glycoproteins in intestinal epithelial cells , 2021, The Journal of biological chemistry.
[6] I. Gut,et al. The ulcerative colitis-associated gene FUT8 regulates the quantity and quality of secreted mucins , 2021, bioRxiv.
[7] D. Quintana,et al. Oxytocin’s dynamic role across the lifespan , 2021, Aging brain.
[8] Yunyun Han,et al. Stimulation of hypothalamic oxytocin neurons suppresses colorectal cancer progression in mice , 2021, eLife.
[9] Rong Lin,et al. Exogenous l‐fucose protects the intestinal mucosal barrier depending on upregulation of FUT2‐mediated fucosylation of intestinal epithelial cells , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Jingxin Li,et al. Oxytocin signalling in dendritic cells regulates immune tolerance in the intestine and alleviates DSS-induced colitis. , 2021, Clinical science.
[11] Ting Zhang,et al. Prognostic role of oxytocin receptor in colon adenocarcinoma , 2021, Open medicine.
[12] A. Bitto,et al. Growth hormone-releasing hormone (GHRH) deficiency promotes inflammation-associated carcinogenesis. , 2019, Pharmacological research.
[13] Yong Feng,et al. Oxytocin Inhibition of Metastatic Colorectal Cancer by Suppressing the Expression of Fibroblast Activation Protein-α , 2019, Front. Neurosci..
[14] Jingxin Li,et al. Oxytocin system alleviates intestinal inflammation by regulating macrophages polarization in experimental colitis. , 2019, Clinical science.
[15] Shengyu Yang,et al. The Diverse Contributions of Fucose Linkages in Cancer , 2019, Cancers.
[16] A. Jakab,et al. Hormone Replacement Therapy in Cancer Survivors – Review of the Literature , 2019, Pathology & Oncology Research.
[17] A. Nakagawara,et al. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma , 2016, Journal of Hematology & Oncology.
[18] S. Markowitz,et al. Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma. , 2016, Gastroenterology.
[19] J. Braun,et al. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice. , 2016, Gastroenterology.
[20] Lai-Xi Wang,et al. Mammalian α-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans* , 2016, The Journal of Biological Chemistry.
[21] Jingxin Li,et al. Oxytocin evokes a pulsatile PGE2 release from ileum mucosa and is required for repair of intestinal epithelium after injury , 2015, Scientific Reports.
[22] O. Martínez-Augustin,et al. Intestinal Inflammation and Mucosal Barrier Function , 2014, Inflammatory bowel diseases.
[23] M. Welch,et al. Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice. , 2014, American journal of physiology. Gastrointestinal and liver physiology.
[24] Lung-Chih Yu,et al. Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells. , 2014, Glycobiology.
[25] S. Grivennikov. Inflammation and colorectal cancer: colitis-associated neoplasia , 2012, Seminars in Immunopathology.
[26] H. Kawashima. Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer. , 2012, Biological & pharmaceutical bulletin.
[27] Stuart M Haslam,et al. Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. , 2012, Nature chemical biology.
[28] Min Zhang,et al. Oxytocin hyperpolarizes cultured duodenum myenteric intrinsic primary afferent neurons by opening BKCa channels through IP3 pathway , 2012, Journal of neurochemistry.
[29] H. Tamir,et al. Expression and developmental regulation of oxytocin (OT) and oxytocin receptors (OTR) in the enteric nervous system (ENS) and intestinal epithelium , 2009, The Journal of comparative neurology.
[30] Markus F Neurath,et al. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.
[31] R. Xavier,et al. Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.
[32] J. Meijerink,et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.
[33] C. Rogers,et al. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus , 2002, The Journal of cell biology.
[34] G. Gimpl,et al. The oxytocin receptor system: structure, function, and regulation. , 2001, Physiological reviews.
[35] N. Sala,et al. Oxytocin reproducing reflex milk ejection in lactating women. , 1974, Journal of applied physiology.